Bailard »

Eliem Therapeutics shares owned by Bailard

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Bailard

Quarter filed Position value Share count Share price at filing
2026-06-30 $142k 11k 13.04
2024-12-31 $102k 57k 1.80

More positions owned by Bailard

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Rus 2000 Val Etf (IWN)
Gilead Sciences (GILD)
Ishares Tr Core Msci Eafe (IEFA)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Calif Mun Bd Etf (CMF)
Amazon (AMZN)

View all positions for Bailard

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics